Core Scientific Announces Third Quarter 2026 Results

Core Scientific Announces Third Quarter 2026 Results MIAMI, Florida, November 5, 2026 - Core Scientific, Inc. (NASDAQ: CORZ), a leader in digital infrastructure for high-density colocation services (“HDC”), today announced financial results for the third quarter ended September 30, 2026. “Our execution at scale is translating into results, with a significant sequential increase in GAAP colocation revenue,” said Adam Sullivan, Chief Executive Officer of Core Scientific. “We are nearing full delivery under our first colocation agreement while construction under our second is underway across five campuses. With revenue growing and substantial contracted capacity still to deliver, we have built a strong foundation for our next phase of growth.” Recent Business Developments •Colocation revenue increased nearly 60% sequentially to $215.4 million in the third quarter of 2026, driven by continued delivery of billing megawatts. •Billing for 485 MW of capacity as of September 30, 2026, representing over $700 million in average annualized colocation GAAP revenue. •Net income increased to $1.2 billion, benefiting from a non-cash gain in the change in fair value of warrants. Adjusted EBITDA more than tripled sequentially to $133.6 million, with margins expanding to 57%, up from 25%. Financial Summary and Operating Metrics (in millions, except billing megawatts) Metric Q3 2026 Q2 2026 Q3 2025 Billing MW 485 395 N/A Colocation Revenue $215.4 $136.7 $15.0 Total Revenue $232.9 $164.2 $81.1 Gross Profit $123.3 $70.0 $3.9 Net income (loss)(1) $1,178.1 $(1,155.3) $(144.0) Adjusted EBITDA $133.6 $41.1 $6.5 Capital Expenditures (“CapEx”)(2) $985.1 $797.5 $244.5 Liquidity and DSRA(3) $1,744.2 $2,601.1 $694.8 (1)Net income (loss) for the quarters ended September 30, 2026 and June 30, 2026 were primarily driven by the change in fair value of warrants, reflecting changes in the Company’s stock price during the periods. (2)CapEx includes purchases of property, plant and equipment and acquisitions of land and development rights. (3)Liquidity and DSRA is comprised of cash and cash equivalents, digital assets, revolver availability, and all restricted cash including the debt service reserve accounts. Restricted cash as of September 30, 2026 and June 30, 2026 included funds held in escrow in connection with certain utility and development costs. As of June 30, 2026, restricted cash also included funds held in escrow for the now closed Polaris DS LLC acquisition. There was no restricted cash as of September 30, 2025. -more- Core Scientific, Inc. Third Quarter 2026 Earnings Release - 2 Conference Call and Earnings Presentation In conjunction with this release, Core Scientific, Inc. will host a conference call today, Thursday, November 5, 2026, at 8:30 am Eastern Time that will be webcast live. Adam Sullivan, Chief Executive Officer, Jim Nygaard, Chief Financial Officer, and Jon Charbonneau, Senior Vice President, Investor Relations will host the call. Investors with Internet access may listen to the live audio webcast via the Investor Relations page of the Core Scientific, Inc. website, http://investors.corescientific.com or by using the following link https://event.choruscall.com/mediaframe/webcast.html?webcastid=9RapppQ4 A supplementary investor presentation for the third quarter 2026 may be accessed at https://investors.corescientific.com/news-events/presentations Audio Replay An audio replay of the event will be archived on the Investor Relations section of the Company's website at http://investors.corescientific.com. About Core Scientific Core Scientific is a leader in designing, building and operating large scale, purpose-built data centers for high-density colocation (“HDC”) services. Core Scientific operates facilities for high-density colocation services serving artificial intelligence-related (“AI”) workloads and is a premier provider of digital infrastructure and services to its third-party customers. The majority of the Company's revenue is derived from high-density colocation services, with the remainder derived from earning digital assets for the Company's own account and from digital asset mining hosting services. The Company is in the process of repurposing its remaining mining facilities to support its high-density colocation services business as circumstances allow. Core Scientific’s facilities are located in Alabama (1), Georgia (2), Kentucky (1), North Carolina (1), North Dakota (1), Oklahoma (1) and Texas (4). To learn more, visit www.corescientific.com. Special Note Regarding Forward-Looking Statements This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”). Forward-looking statements may include words such as “aim,” “estimate,” “plan,” “project,” “forecast,” “goal,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding projections, estimates and forecasts of revenue, contracted revenue and other financial and performance metrics, projections of market opportunity and expectations, the Company’s ability to scale and grow its business, successfully finance and complete construction of its data centers, source sufficient electrical energy, necessary long lead infrastructure components, supplies and equipment, the expected growth of the Company, the Company’s ability to source and retain talent, and our ability to source and acquire suitable additional land and power. These statements are provided for illustrative purposes only and are based on various assumptions, whether or not identified in this press release, and on the current expectations of the Company’s management. These forward-looking statements are not intended to serve, and must not be relied on by any investor, as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to -more- Core Scientific, Inc. Third Quarter 2026 Earnings Release - 3 predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions, known or unknown, that could cause actual results to vary materially from those indicated or anticipated. These risks, assumptions and uncertainties include those described in Part I. Item 1A. — “Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and in the Company’s Quarterly Reports on Form 10-Q. If one or more of these risks or uncertainties materializes, or if underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. There may be additional risks that the Company could not presently know or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect the Company’s expectations, plans or forecasts of future events and views as of the date of this press release and should not be relied upon as representing the Company’s assessments as of any date subsequent to the date of this press release. The Company anticipates that subsequent events and developments will cause the Company’s assessments to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. Accordingly, you should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. -more- Core Scientific, Inc. Third Quarter 2026 Earnings Release - 4 Core Scientific, Inc. Condensed Consolidated Balance Sheets (Unaudited, in thousands, except par value) September 30, 2026 June 30, 2026 December 31, 2025 Assets Current Assets: Cash and cash equivalents $ 803,941 $ 1,769,735 $ 311,378 Digital assets 2,690 49,675 222,000 Customer funding receivable 282,659 383,758 337,158 Restricted cash, current portion 201,745 165,745 — Other current assets 131,115 74,731 25,001 Total Current Assets 1,422,150 2,443,644 895,537 Property, plant and equipment, net 2,630,353 1,774,142 1,293,299 Intangibles, net 737,531 228,625 1,076 Operating lease right-of-use assets 110,503 114,199 108,484 Deferred lease incentive, net of current portion 295,000 — — Restricted cash, net of current portion 635,858 615,911 — Other noncurrent assets 104,319 80,972 49,248 Total Assets $ 5,935,714 $ 5,257,493 $ 2,347,644 Liabilities and Stockholders’ Deficit Current Liabilities: Accounts payable $ 120,876 $ 112,374 $ 126,106 Accrued expenses 779,520 509,189 511,957 Deferred revenue, current portion 309,065 287,201 127,561 Warrant liabilities, current portion 880,725 1,811,587 — Other current liabilities 17,028 17,443 15,777 Total Current Liabilities 2,107,214 2,737,794 781,401 Long-term debt 4,302,175 4,297,967 1,060,325 Deferred revenue, net of current portion 264,506 367,242 428,290 Warrant liabilities, net of current portion 238,180 163,683 936,107 Other noncurrent liabilities 115,717 110,163 104,261 Total Liabilities 7,027,792 7,676,849 3,310,384 Commitments and contingencies Stockholders’ Deficit: Preferred stock; $0.00001 par value; 2,000,000 shares authorized; none issued and outstanding at September 30, 2026 and December 31, 2025 — — — Common stock; $0.00001 par value; 10,000,000 shares authorized at September 30, 2026 and December 31, 2025; 321,972 and 314,231 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively 3 3 3 Additional paid-in capital 3,378,990 3,229,842 3,183,960 Accumulated deficit (4,471,071) (5,649,201) (4,146,703) Total Stockholders’ Deficit (1,092,078) (2,419,356) (962,740) Total Liabilities and Stockholders’ Deficit $ 5,935,714 $ 5,257,493 $ 2,347,644 Certain prior year amounts have been reclassified for consistency with the current year presentation. -more- Core Scientific, Inc. Third Quarter 2026 Earnings Release - 5 Core Scientific, Inc. Condensed Consolidated Statements of Operations (Unaudited, in thousands, except per share amounts) Three Months Ended Nine Months Ended September 30, 2026 June 30, 2026 September 30, 2025 September 30, 2026 September 30, 2025 Revenue: Colocation revenue $ 215,432 $ 136,669 $ 14,951 $ 429,640 $ 34,084 Digital asset self-mining revenue 12,263 21,535 57,438 63,903 187,041 Digital asset hosted mining revenue 5,171 5,997 8,714 18,768 18,131 Total revenue 232,866 164,201 81,103 512,311 239,256 Cost of revenue: Cost of colocation services 87,059 56,686 11,066 177,363 28,602 Cost of digital asset self-mining 19,755 33,700 59,438 100,644 180,197 Cost of digital asset hosted mining services 2,780 3,771 6,694 10,882 13,314 Total cost of revenue 109,594 94,157 77,198 288,889 222,113 Gross profit 123,272 70,044 3,905 223,422 17,143 Loss (gain) on fair value of digital assets (19,264) 9,368 (10,957) (3,338) (30,066) Loss on disposal of property, plant and equipment 5,342 1,273 300 20,253 4,472 Loss on remeasurement of assets held for sale, net 1,518 19,495 — 21,013 — Impairment of property, plant and equipment — — — 266,488 — Loss on contract termination — 41,948 — 41,948 — Colocation organizational and site startup costs 12,932 27,039 16,174 48,636 39,496 Advisor fees 4,839 381 5,785 5,553 7,083 Selling, general and administrative 45,555 49,008 47,395 139,408 124,272 Operating income (loss) 72,350 (78,468) (54,792) (316,539) (128,114) Non-operating expenses (income), net: Loss on debt extinguishment — 5,435 — 5,435 1,377 Interest expense (income), net 35,047 23,833 (821) 63,737 (4,193) Change in fair value of warrants and contingent value rights (1,034,358) 1,045,515 74,864 41,956 363,358 Loss on legal settlements — — 15,075 500 15,504 Other non-operating expenses (income), net 37 152 (8) 200 (73) Total non-operating expenses (income), net (999,274) 1,074,935 89,110 111,828 375,973 Income (loss) before income tax expense (benefit) 1,071,624 (1,153,403) (143,902) (428,367) (504,087) Income tax expense (benefit) (106,506) 1,907 125 (103,999) 488 Net income (loss) $ 1,178,130 $ (1,155,310) $ (144,027) $ (324,368) $ (504,575) Net income (loss) per share, basic $ 3.42 $ (3.32) $ (0.45) $ (0.93) $ (1.48) Net income (loss) per share, diluted $ 0.47 $ (3.32) $ (0.45) $ (0.93) $ (1.48) Weighted average shares outstanding, basic 327,700 325,329 318,562 325,334 317,363 Weighted average shares outstanding, diluted 469,006 325,329 318,562 325,334 317,363 -more- Core Scientific, Inc. Third Quarter 2026 Earnings Release - 6 Supplemental information - stock based compensation: Cost of revenue $ 685 $ 1,283 $ 1,251 $ 2,821 $ 3,574 Colocation organizational and site startup costs 6,584 4,302 7,241 15,110 14,831 Selling, general and administrative 17,916 12,655 21,454 43,255 51,896 Stock-based compensation expense, net of amounts capitalized 25,185 18,240 29,946 61,186 70,301 Capitalized stock-based compensation 57 519 227 1,202 623 Total stock-based compensation cost $ 25,242 $ 18,759 $ 30,173 $ 62,388 $ 70,924 Certain prior year amounts have been reclassified for consistency with the current year presentation. -more- Core Scientific, Inc. Third Quarter 2026 Earnings Release - 7 Core Scientific, Inc. Condensed Consolidated Statements of Cash Flows (Unaudited, in thousands) Nine Months Ended September 30, 2026 2025 Cash flows from Operating Activities: Net loss $ (324,368) $ (504,575) Adjustments to reconcile net loss to net cash provided by operating activities: Depreciation and amortization 50,133 54,816 Loss on disposal of property, plant and equipment 20,253 4,472 Loss on remeasurement of assets held for sale, net 21,013 — Impairment of property, plant and equipment 266,488 — Change in operating lease right-of-use assets 10,046 8,248 Stock-based compensation 61,186 70,301 Digital asset self-mining revenue (63,903) (187,396) Proceeds from sales of digital assets generated by self-mining revenue(1) 286,765 — Gain on fair value of digital assets (3,338) (30,066) Change in fair value of warrants and contingent value rights 41,956 363,358 Loss on debt extinguishment 5,435 1,377 Deferred income taxes (105,816) — Accrued interest capitalized to construction in progress (23,273) — Changes in operating assets and liabilities: Customer funding receivable 54,499 (335,643) Accounts payable (82,177) 105,615 Accrued expenses 167,124 244,977 Deferred revenue from colocation services 19,151 323,796 Other current assets (50,979) 11,500 Other operating assets and liabilities, net (53,952) (10,040) Net cash provided by operating activities 296,243 120,740 Cash flows from Investing Activities: Purchases of property, plant and equipment (1,494,979) (449,752) Proceeds from sales of property, plant and equipment 6,094 1,929 Cash paid for asset acquisitions (676,881) — Other investing activities (149) (15,160) Net cash used in investing activities (2,165,915) (462,983) Cash flows from Financing Activities: Debt extinguishment payments (1,000,000) (26,862) Proceeds from the issuance of debt 4,275,250 — Debt issuance costs (50,907) — Taxes paid related to net share settlement of equity awards (35,152) (5,893) Principal payments on debt — (8,613) Proceeds from exercise of warrants 11,742 1,746 Other financing activities (1,095) (1,672) Net cash provided by (used in) financing activities 3,199,838 (41,294) Net increase (decrease) in cash, cash equivalents and restricted cash 1,330,166 (383,537) Cash, cash equivalents and restricted cash—beginning of period 311,378 836,980 Cash, cash equivalents and restricted cash—end of period $ 1,641,544 $ 453,443 Supplemental disclosures of other cash flow information: Cash paid for interest, net of capitalized interest $ 19,313 $ 15,285 Income tax payments 640 $ 298 -more- Core Scientific, Inc. Third Quarter 2026 Earnings Release - 8 Supplemental disclosures of non-cash investing and financing activities: Purchases of property, plant and equipment in accounts payable and accrued expenses $ 429,937 $ 154,440 Reclass of property, plant and equipment to held for sale $ 51,262 $ — Operating lease right-of-use assets obtained in exchange for lease obligations $ 13,440 $ 2,154 Non-cash exercise of warrants $ 1,514 $ 24,692 Liabilities assumed in acquisition $ 115,790 $ — Issuance of warrants $ 296,423 $ — Interest capitalized to construction in progress $ 25,828 $ — Reconciliation of cash, cash equivalents and restricted cash within the Condensed Consolidated Balance Sheets to the amounts shown in the Condensed Consolidated Statements of Cash Flows above: Cash and cash equivalents $ 803,941 $ 453,443 Restricted cash, current portion 201,745 — Restricted cash, net of current portion 635,858 — Total cash, cash equivalents and restricted cash $ 1,641,544 $ 453,443 (1)Proceeds from digital assets received as noncash revenue consideration liquidated at management's discretion. Certain prior year amounts have been reclassified for consistency with the current year presentation. -more- Core Scientific, Inc. Third Quarter 2026 Earnings Release - 9 Core Scientific, Inc. Segment Results (Unaudited, in thousands, except percentages) Three Months Ended Nine Months Ended September 30, 2026 June 30, 2026 September 30, 2025 September 30, 2026 September 30, 2025 Colocation Segment Colocation revenue: License fees $ 157,265 $ 98,812 $ 9,848 $ 315,272 $ 22,853 Power fees passed through to customer 57,556 35,073 3,553 113,689 9,603 Maintenance and other 611 2,784 1,550 679 1,628 Total colocation revenue 215,432 136,669 14,951 429,640 34,084 Cost of colocation services: Power fees passed through to customer 57,556 35,073 3,553 113,689 9,604 Depreciation expense 10,061 4,621 219 16,757 389 Employee compensation 6,419 4,801 2,209 14,206 4,651 Facility operations expense 10,371 10,381 4,383 27,507 12,570 Other segment items(1) 2,652 1,810 702 5,204 1,388 Total cost of colocation services 87,059 56,686 11,066 177,363 28,602 Colocation gross profit $ 128,373 $ 79,983 $ 3,885 $ 252,277 $ 5,482 Colocation gross margin 60 % 59 % 26 % 59 % 16 % Digital Asset Self-Mining Segment Digital asset self-mining revenue $ 12,263 21,535 $ 57,438 $ 63,903 $ 187,041 Cost of digital asset self-mining: Power fees 10,483 17,861 33,280 55,614 94,319 Depreciation expense 7,173 9,897 15,474 30,978 52,792 Employee compensation 1,255 4,052 7,803 8,834 23,411 Facility operations expense 636 1,286 2,089 3,895 7,458 Other segment items(1) 208 604 792 1,323 2,217 Total cost of digital asset self-mining 19,755 33,700 59,438 100,644 180,197 Digital Asset Self-Mining gross profit $ (7,492) $ (12,165) $ (2,000) $ (36,741) $ 6,844 Digital Asset Self-Mining gross margin (61) % (56) % (3) % (57) % 4 % Digital Asset Hosted Mining Segment Digital asset hosted mining revenue from customers $ 5,171 5,997 $ 8,714 $ 18,768 $ 18,131 Cost of digital asset hosted mining services: Power fees 1,987 2,356 4,793 7,646 9,367 Depreciation expense 401 626 376 1,332 856 Employee compensation 233 542 1,115 1,202 2,225 Facility operations expense 119 167 297 520 665 Other segment items(1) 40 80 113 182 201 Total cost of digital asset hosted mining services 2,780 3,771 6,694 10,882 13,314 Digital Asset Hosted Mining gross profit $ 2,391 $ 2,226 $ 2,020 $ 7,886 $ 4,817 Digital Asset Hosted Mining gross margin 46 % 37 % 23 % 42 % 27 % Consolidated Consolidated total revenue $ 232,866 $ 164,201 $ 81,103 $ 512,311 $ 239,256 Consolidated cost of revenue $ 109,594 $ 94,157 $ 77,198 $ 288,889 $ 222,113 Consolidated gross profit $ 123,272 $ 70,044 $ 3,905 $ 223,422 $ 17,143 Consolidated gross margin 53 % 43 % 5 % 44 % 7 % (1)Other segment items consist primarily of software and IT costs, travel, professional and contract services, and telecommunications costs. -more- Core Scientific, Inc. Third Quarter 2026 Earnings Release - 10 Core Scientific, Inc. Non-GAAP Financial Measures (Unaudited) Adjusted EBITDA is a non-GAAP financial measure defined as our net loss, adjusted to eliminate the effect of (i) interest expense (income), net; (ii) provision for income taxes; (iii) depreciation and amortization; (iv) stock-based compensation expense; (v) loss on disposal and impairment of property, plant and equipment; (vi) loss on remeasurement of assets held for sale; (vii) loss on contract termination; (viii) colocation organizational startup costs primarily related to the initial ramp up of new colocation sits and the conversion of existing facilities to colocation data center operations; (ix) loss on debt extinguishment; (x) change in fair value of warrant and contingent value rights; (xi) loss on legal settlements; (xii) post-emergence bankruptcy advisory costs incurred related to reorganization and (xiii) certain additional non-cash items that do not reflect the performance of our ongoing business operations. For additional information, including the reconciliation of net loss to Adjusted EBITDA, please refer to the table below. We believe Adjusted EBITDA is an important measure because it allows management, investors, and our Board of Directors to evaluate and compare our operating results, including our return on capital and operating efficiencies, from period-to-period by making the adjustments described above. In addition, it provides useful information to investors and others in understanding and evaluating our results of operations, as well as provides a useful measure for period-to-period comparisons of our business, as it removes the effect of net interest expense, taxes, certain non-cash items, variable charges and timing differences. Moreover, we have included Adjusted EBITDA in this earnings release because it is a key measurement used by our management internally to make operating decisions, including those related to operating expenses, evaluate performance, and perform strategic and financial planning. The above items are excluded from our Adjusted EBITDA measure because these items are non-cash in nature or because the amount and timing of these items are not related to the current results of our core business operations which renders evaluation of our current performance, comparisons of performance between periods and comparisons of our current performance with our competitors less meaningful. However, you should be aware that when evaluating Adjusted EBITDA, we may incur future expenses similar to those excluded when calculating this measure. Our presentation of this measure should not be construed as an inference that its future results will be unaffected by unusual items. Further, this non-GAAP financial measure should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). We compensate for these limitations by relying primarily on GAAP results and using Adjusted EBITDA on a supplemental basis. Our computation of Adjusted EBITDA may not be comparable to other similarly titled measures computed by other companies because not all companies calculate this measure in the same fashion. You should review the reconciliation of net loss to Adjusted EBITDA below and not rely on any single financial measure to evaluate our business. -more- Core Scientific, Inc. Third Quarter 2026 Earnings Release - 11 The following table reconciles the non-GAAP financial measure to the most directly comparable U.S. GAAP financial performance measure, which is net loss, for the periods presented (in thousands): Three Months Ended Nine Months Ended September 30, 2026 June 30, 2026 September 30, 2025 September 30, 2026 September 30, 2025 Adjusted EBITDA Net income (loss) $ 1,178,130 $ (1,155,310) $ (144,027) $ (324,368) $ (504,575) Adjustments: Interest expense (income), net 35,047 23,833 (821) 63,737 (4,193) Income tax expense (benefit) (106,506) 1,907 125 (103,999) 488 Depreciation and amortization 17,987 15,498 16,329 50,133 54,816 Stock-based compensation expense 18,601 13,938 22,705 46,076 55,470 Loss on disposal of property, plant and equipment 5,342 1,273 300 20,253 4,472 Loss on remeasurement of assets held for sale, net 1,518 19,495 — 21,013 — Impairment of property, plant and equipment — — — 266,488 — Colocation organizational and site startup costs(1) 12,932 27,039 16,174 48,636 39,496 Loss on contract termination — 41,948 — 41,948 — Loss on debt extinguishment — 5,435 — 5,435 1,377 Change in fair value of warrants and contingent value rights (1,034,358) 1,045,515 74,864 41,956 363,358 Loss on legal settlements — — 15,075 500 15,504 Post-emergence bankruptcy advisory costs(2) 29 397 278 743 1,576 Merger transaction advisor fees(2) 4,809 (16) 5,507 4,809 5,507 Other 37 151 (8) 200 (73) Adjusted EBITDA $ 133,568 $ 41,103 $ 6,501 $ 183,560 $ 33,223 (1)Included in Colocation organizational and site startup costs are costs associated to Stock-based compensation expense of $6.6 million, $4.3 million, and $7.2 million for the three months ended September 30, 2026, June 30, 2026, and September 30, 2025, respectively, and $15.1 million and $14.8 million for the nine months ended September 30, 2026 and 2025, respectively. For the nine months ended September 30, 2025, there was also $4.4 million in site conversion demolition costs. (2)Included in Advisor fees on the condensed consolidated statements of operations. -more- Core Scientific, Inc. Third Quarter 2026 Earnings Release - 12 Term Library Term (MW) Definition How management uses it Gross Utility Power Capacity Total electric utility power capacity agreements associated with our data center sites under our control as of period end, including capacity that is commissioned for future use. Used for portfolio planning and utility power allocation discussions. Total Leasable Customer Power Capacity Our estimate of the total non-redundant customer IT load that our data center sites could support in the aggregate as of period end, regardless of whether such capacity has been contracted with customers or remains available for sale. This metric is representative of the amount of power available for customer use in servicing their workloads. Used to assess total customer usable IT load available for leasing, evaluate leased versus unleased capacity, and plan conversion/development sequencing and sales capacity. Leased Customer Power Capacity Power capacity that is committed to customers under executed customer contracts, regardless of whether service has commenced as of period end. Used to monitor signed customer commitments and contracted backlog and to plan future deployment/commissioning requirements. Unleased Customer Power Capacity The portion of Total Leasable Customer Power Capacity not committed under customer contracts as of period end. This metric is calculated as Total Leasable Customer Power Capacity minus Leased Customer Power Capacity. Used to monitor remaining uncommitted customer IT load and to prioritize incremental contracting and conversion/commissioning plans. Billable Customer Power Capacity Portion of Leased Customer Power Capacity for which service has commenced, and we are actively billing as of period end. Used to monitor in-service customer power that is billing and to track deployment/commissioning pace and near-term revenue ramp. -more- Core Scientific, Inc. Third Quarter 2026 Earnings Release - 13 ///////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////// Please follow us on: https://www.linkedin.com/company/corescientific/ https://twitter.com/core_scientific https://www.youtube.com/@Core_Scientific CONTACTS Investors: ir@corescientific.com Media: press@corescientific.com -end-